Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at TD Cowen from $25.00 to $28.00. They now have a "buy" rating on the stock.
MediumReport
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at TD Cowen from $25.00 to $28.00. They now have a "buy" rating on the stock.
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $23.00 to $27.00. They now have a "hold" rating on the stock.
LowReport
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $23.00 to $27.00. They now have a "hold" rating on the stock.
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
"Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ blog email newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our blog below: